Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ziphius logo — Diving deeper to uncover the possibilities of self-amplifyin...

Ziphius

Diving deeper to uncover the possibilities of self-amplifying RNA.

Founded 2019 Belgium Belgium 60 employees Total: $24.30M Biotechnology, Pharmaceutical

General Information

Company Name Ziphius
Founded Year 2019
Location Belgium Belgium
Employees 60
Industries Biotechnology, Pharmaceutical
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Ziphius. To contact Ziphius, visit ziphius.org.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ziphius compare?

A PDF of Ziphius and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ziphius soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ziphius

Ziphius, a Belgium-based company founded in 2019, operates in the Biotechnology and Pharmaceutical industries. Their mission, encapsulated in the slogan, "Diving deeper to uncover the possibilities of self-amplifying RNA," highlights their focus on innovative RNA technologies.

This startup has captured the attention of investors, with a notable €24.30M convertible note investment on 01 May 2021. Key investors include industry veterans Annie Vereecken and Christian Dumolin, signaling strong confidence in the company’s potential for growth and advancement in RNA research.

Business keywords: self-amplifying RNA, biopharmaceutical, vaccine development, infectious disease prevention, next-generation vaccines, RNA technology, biotech innovation, vaccine biotechnology, therapeutic RNA

Services & Products

Development of self-amplifying RNA technologies
Innovative solutions for infectious diseases
Advanced treatments for rare diseases
Next-generation oncology therapies
Custom lipid nanoparticle delivery systems

Target Customers

Pharmaceutical companies Researchers in biotechnology Healthcare providers Oncology specialists Organizations focused on rare diseases

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note €24.30M 2
Annie Vereecken, Christian Dumolin
01 May 2021

Ziphius Alternatives & Competitors

View All Alternatives
Ziphius vs
Anodyne Nanotech, Inc
Anodyne Nanotech, Inc United States

Simplifying Chronic Care

20 employees
Biopharma, Biotechnology
Compare Ziphius vs Anodyne Nanotech, Inc
Ziphius vs
Aro Biotherapeutics
Aro Biotherapeutics United States

Series B
51 employees
Biotechnology, Health Care
Compare Ziphius vs Aro Biotherapeutics
Ziphius vs
KAICO Ltd.
KAICO Ltd. Japan

Changing the World with Silkworms

Series B
10 employees
Biotechnology, Pharmaceutical
Also compare with: Ziphius vs Innovac Therapeutics Innovac Therapeutics View all alternatives

FAQ About Ziphius

Diving deeper to uncover the possibilities of self-amplifying RNA.
Ziphius was founded in 2019.
Ziphius is headquartered in Belgium.
Ziphius operates in Biotechnology and Pharmaceutical. Its work centres on self-amplifying RNA, biopharmaceutical, vaccine development and infectious disease prevention. Its customers include Pharmaceutical companies, Researchers in biotechnology and Healthcare providers.
Ziphius has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Ziphius has approximately 60 employees.
Ziphius has completed 1 funding round, raising a total of $24.30M.
Ziphius offers: Development of self-amplifying RNA technologies, Innovative solutions for infectious diseases, Advanced treatments for rare diseases, Next-generation oncology therapies, Custom lipid nanoparticle delivery systems.
Top alternatives and competitors to Ziphius include Anodyne Nanotech, Inc, Aro Biotherapeutics, KAICO Ltd., ReCode Therapeutics, Affinivax Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ziphius and Anodyne Nanotech, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ziphius, https://bouncewatch.com/company/ziphius, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout